---
title: "CytomX Therapeutics appoints Charles Fuchs to board of directors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293928575.md"
description: "CytomX Therapeutics has appointed Charles Fuchs to its board of directors. Fuchs brings extensive experience, having served as Chief Medical Officer at Tubulis and previously leading oncology and hematology drug development at Genentech and Roche. CytomX highlighted his gastrointestinal oncology expertise as particularly relevant to its pipeline asset, Varseta-M, an EpCAM-targeted antibody-drug conjugate in development for metastatic colorectal cancer."
datetime: "2026-07-27T12:02:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293928575.md)
  - [en](https://longbridge.com/en/news/293928575.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293928575.md)
generator: "portal-rs"
---

# CytomX Therapeutics appoints Charles Fuchs to board of directors

-   CytomX Therapeutics appointed Charles Fuchs to its board of directors. \* Fuchs most recently served as chief medical officer at Tubulis, overseeing clinical strategy and pipeline development. \* He previously led oncology and hematology drug development at Genentech and Roche, advancing multiple therapies through approval. \* CytomX flagged Fuchs’ gastrointestinal oncology experience as relevant to Varseta-M, its EpCAM-targeted ADC in development for metastatic colorectal cancer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytomX Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607270800PRIMZONEFULLFEED9765914) on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CTMX.US](https://longbridge.com/en/quote/CTMX.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [RHHVF.US](https://longbridge.com/en/quote/RHHVF.US.md)

## Related News & Research

- [CytomX Therapeutics doubles authorized common shares to 600 million](https://longbridge.com/en/news/290478262.md)
- [Sugar Prices Rally as India Cuts Sugar Import Duties](https://longbridge.com/en/news/296518344.md)
- [Oil prices mixed; may be buoyed amid deadlock in US.-Iran talks](https://longbridge.com/en/news/296041997.md)
- [Greenland Mines Ltd trading halted, news pending](https://longbridge.com/en/news/296671630.md)
- [Energy Department eyes American oil comeback](https://longbridge.com/en/news/296139041.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**